In January 2020, rare disease biopharma Insmed (Nasdaq: INSM) hired Sara Bonstein as its chief financial officer. At that point, Bonstein had more than 15 years of operational and financial experience in the life sciences industry. In the following interview highlighting her role as a female pharma leader, Bonstein shares what initially attracted her to…